- Raised $2.5M Pre-Seed round led by Peregrine Ventures
- Raised Series A led by Peregrine Ventures, Sep 2025
- Raised Seed round led by Peregrine Ventures, Feb 2024
About
Terrapeutics Pharma is a drug discovery company that utilizes a groundbreaking platform technology combining synthetic biology, sequencing tools, and computational biology to discover novel small therapeutic molecules from soil-based bacteria. The company focuses on tackling 'undruggable' drug targets, with a lead program in pan KRAS inhibitors for cancer treatment and additional programs for infectious diseases. Their technology aims to unlock the vast potential of natural molecules for drug discovery, which are largely unexplored by conventional methods. Terrapeutics' platform, AIM-N (Activated Induction of Metabolites in Nature), disrupts a natural soil environment with an engineered microorganism to force residents to produce small molecules against a predefined drug target.
Funding history · 3 rounds · $2.5M total
Headcount over time
Q&A
- What is Terrapeutics Pharma's primary focus?
- Terrapeutics Pharma is a drug discovery company that uses a platform combining synthetic biology, sequencing tools, and computational biology to discover novel small therapeutic molecules from soil-based bacteria. The company focuses on tackling 'undruggable' drug targets, with a lead program in pan KRAS inhibitors for cancer treatment.
- When was Terrapeutics Pharma founded?
- Terrapeutics Pharma was founded in 2019.
- How many employees does Terrapeutics Pharma currently have?
- Terrapeutics Pharma has 7 employees, falling within the 1-10 employee bucket.
- What is the total amount of funding Terrapeutics Pharma has raised to date?
- Terrapeutics Pharma has raised a total of $2,500,000 USD.
- Which investors participated in Terrapeutics Pharma's Seed round in October 2025?
- In October 2025, Terrapeutics Pharma raised $730,000 in a Seed round with participation from Illumina.
- What is the name of Terrapeutics Pharma's drug discovery platform?
- Terrapeutics Pharma's drug discovery platform is called AIM-N (Activated Induction of Metabolites in Nature).
- What is Terrapeutics Pharma's lead discovery program focused on?
- Terrapeutics Pharma's lead discovery program focuses on pan KRAS inhibitors for cancer treatment.
- Where is Terrapeutics Pharma headquartered?
- Terrapeutics Pharma is headquartered in Jerusalem, Israel.
Team · 2
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | terrapeuticspharma.com |
|---|---|
| linkedin.com/company/80039518 |
Identifiers & details
| Legal name | TERRAPEUTICS PHARMA LTD |
|---|---|
| Founded | 2019 |
| Employees (exact) | 7 |
| Offices | Alameda |
Radar intelligence
Web history (Wayback)
| Domain | terrapeuticspharma.com |
|---|
Certificate / subdomain footprint
| Subdomains | 3 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515804607 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2018-02-22 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | דרך חברון 58 ירושלים |